Erster intravenöser Migräne-Antikörper zugelassen
Crossref DOI link: https://doi.org/10.1007/s15006-022-1012-y
Published Online: 2022-04-01
Published Print: 2022-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2022-04-01
Version of Record valid from 2022-04-01
Article History
First Online: 1 April 2022
Free to read: This content has been made available to all.